DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L.
Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer's disease.
J Prev Alzheimers Dis 2018;
5 (02) 149-154
Access:
We do not assume any responsibility for the contents of the web pages of other providers.